Distribution of killer cell immunoglobulin-like receptor (KIR) genes in a large, multi-centre cohort of Chinese donors

He, Ming; Zheng, Zhong-Zheng; He, Qingqing; Li, Dai-Yang; Liao, Kuanzhen; An, L.; Weng, Qi; Wang, Ning-Juan; Wang, Liping; Sun, Qin; Wang, Jian; Xiao, Pei-Li; Du, Ke‐Ming; Jiang, Ming

doi:10.1080/03014460.2021.1913223

Cited by 1 publication

(2 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The frequencies of individual KIR genes in our cohort were comparable to the published data in healthy populations 30,31 . The cumulative incidence of EBV reactivation by day 100 post‐transplantation was significantly higher in patients who accepted a KIR2DS1‐positive donor compared to patients who accepted a KIR2DS1‐negative donor [rate/incidence (95%CI) 34·58% (25·42%, 43·74%) vs. 20·21% (14·49%, 25·92%), P = 0·0067] (Fig 1A).…”

Section: Resultssupporting

confidence: 85%

“…The frequencies of individual KIR genes in our cohort were comparable to the published data in healthy populations. 30,31 The cumulative incidence of EBV reactivation by day 100 posttransplantation was significantly higher in patients who accepted a KIR2DS1-positive donor compared to patients who accepted a KIR2DS1-negative donor [rate/incidence (95%CI) 34Á58% (25Á42%, 43Á74%) vs. 20Á21% (14Á49%, 25Á92%), P = 0Á0067] (Fig 1A). The cumulative incidences indicated that the EBV reactivation rate was higher in patients whose graft was positive for KIR2DS3 than patients whose graft was negative for KIR2DS3 [rate/incidence (95%CI) 37Á25% (23Á52%, 50Á99%) vs. 22Á89% (17Á64%, 28Á15%), P = 0Á030] (Fig 1B).…”

Section: Donor Akir Genes Contribute To Ebv Reactivationmentioning

confidence: 99%

See 1 more Smart Citation

Donor activating killer cell immunoglobulin‐like receptors genes correlated with Epstein–Barr virus reactivation after haploidentical haematopoietic stem cell transplantation

et al. 2021

View full text Add to dashboard Cite

Natural killer (NK) cells exert anti-viral effects after haematopoietic stem cell transplantation (HSCT). The balance between inhibition and activation of NK cells determined by the inherited repertoire of killer cell immunoglobulin-like receptors (KIR) genes may influence Epstein-Barr virus (EBV) reactivation after transplantation. To evaluate the relative contributions of KIR genotypes to EBV reactivation, we prospectively enrolled 300 patients with malignant haematological disease who were suitable for haploidentical HSCT. Univariate analysis showed that donors with KIR2DS1, KIR2DS3 or KIR3DS1 genes were associated with an increased risk of EBV reactivation [hazard ratio (HR) 1Á86, 95% confidence interval (CI) 1Á19-2Á9, P = 0Á0067; HR 1Á78, 95% CI 1Á07-2Á97, P = 0Á027; HR 1Á86, 95% CI 1Á19-2Á91, P = 0Á0065 respectively]. Multivariate analysis revealed that the presence of KIR2DS1, KIR2DS3 or KIR3DS1 genes was associated with increased EBV reactivation after HSCT. This effect was more evident in the absence of the cognate ligands for the corresponding activating receptors. Our present data firstly showed that donors with activating KIR genes, specifically activating KIR2DS1, KIR2DS3 and KIR3DS1, had an increased risk of EBV reactivation. Precaution for patients whose donors carry activating genes will help prevent EBV reactivation and improve patient prognosis after HSCT.

show abstract

Section: Resultssupporting

confidence: 85%

Section: Donor Akir Genes Contribute To Ebv Reactivationmentioning

confidence: 99%